Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000895345-24-000549
Filing Date
2024-11-07
Accepted
2024-11-07 21:35:56
Documents
1
Group Members
AARON I. DAVISBCTG HOLDINGS, LLCBOXER CAPITAL MANAGEMENT LLCMVA INVESTORS, LLC

Document Format Files

Seq Description Document Type Size
1 ff4095518_13da-boxertango.htm SC 13D/A 142169
  Complete submission text file 0000895345-24-000549.txt   144024
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Subject) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92241 | Film No.: 241437759
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12860 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12860 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 8584003115
Boxer Capital Management, LLC (Filed by) CIK: 0002018299 (see all company filings)

EIN.: 990921494 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A